JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M304629200 on June 3, 2003

J. Biol. Chem., Vol. 278, Issue 34, 32047-32057, August 22, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/34/32047    most recent
M304629200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Myers, J. C.
Right arrow Articles by Weisel, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Myers, J. C.
Right arrow Articles by Weisel, J. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Type XIX Collagen Purified from Human Umbilical Cord Is Characterized by Multiple Sharp Kinks Delineating Collagenous Subdomains and by Intermolecular Aggregates via Globular, Disulfide-linked, and Heparin-binding Amino Termini*

Jeanne C. Myers {ddagger} §, Deqin Li {ddagger}, Peter S. Amenta ¶, Charles C. Clark {ddagger} ||, Chandrasekaran Nagaswami ** and John W. Weisel **

From the Departments of {ddagger}Biochemistry and Biophysics, ||Orthopaedic Surgery, and **Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 and the Department of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903

Received for publication, May 2, 2003 , and in revised form, May 29, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Type XIX collagen was discovered from the sequence of rhabdomyosarcoma cDNA clones. The chain is composed of a 268-residue amino terminus, an 832-residue discontinuous collagenous region, and a 19-residue carboxyl peptide. Light microscopy immunohistochemistry of adult human tissues demonstrated that type XIX is localized in vascular, neuronal, mesenchymal, and some epithelial basement membrane zones. It also appears to be involved in events linked to skeletal myogenesis. In this report, we have presented the first direct evidence for the molecular structure of type XIX collagen. Using human umbilical cord, native type XIX was purified by neutral salt extraction and by ion exchange and antibody affinity chromatography. Type XIX was found to represent only ~106% of the dry weight of tissue, making it by far the least abundant collagen ever isolated. Transmission electron microscopy after rotary shadowing revealed the appearance of rodlike structures with multiple sharp bends, a small nodule at one end of the molecule, and a total length of 240 nm. Domain-specific antibodies were used to identify the nodule as the noncollagenous amino terminus, whereas the location of most kinks corresponds to major interruptions separating the five collagenous subdomains. More than half of the type XIX molecules observed were present in oligomers of different size and complexity, resulting from association of the amino-terminal domains. Biochemical analysis demonstrated that these supramolecular aggregates are dependent upon and/or stabilized by intermolecular disulfide cross-links and that the globular amino terminus contains a high affinity, heparin-binding site. The polymorphic conformational states of this rare collagen, and its ability to self-assemble into a higher order structure provide focal points for future determination of biologically significant functions in cell-cell and/or cell-matrix interactions.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Twenty-six collagen types have currently been designated; seven of these are recent discoveries, and several have yet to be described (17). With the diversity that this family has presented, one of the few defining elements is the existence of one or more triple-helical regions, regardless of size and relative proportion to the entire protein. In the most general sense, therefore, collagens have been divided into the classic fibrillar group (i.e. those containing the ~333 continuous Gly-X-Y triplets and involved in the formation of cross-striated fibrils) and the nonfibrillar group, a highly heterogeneous class exhibiting a spectrum of sizes, supramolecular assemblies, and chain organization, with the one commonality being the presence of noncollagenous sequences interrupting and/or flanking collagenous domains (1, 2, 810). Understanding the complex structure and function of these many proteins has proven to be a formidable task despite, in many instances, extensive knowledge of disease phenotypes directly attributable to the respective collagen gene mutations (1, 11, 12). A major complication in this process has been the scarcity of a number of collagen types and the inability to directly characterize the in vivo form of the molecules. One of these elusive and increasingly intriguing collagens is type XIX.

Type XIX collagen was identified from independently isolated clones representing RNA purified from a human rhabdomyosarcoma (RMS)1 cell line (13, 14). The type XIX chain is composed of a 268-residue, noncollagenous amino terminus, an 832-residue discontinuous collagenous region, and a 19-residue carboxyl peptide (1416). Several features in the type XIX sequence place this collagen in the largest subclass of the nonfibrillar group, together with types IX, XII, XIV, XVI, XX, and XXI (24, 10). These include an ~250-residue thrombospondin module in the amino terminus (Tsp-N), the position of two 2-amino acid interruptions in the collagenous subdomain closest to the carboxyl terminus, and a Cys-Xaa4-Cys motif situated at the junction of the collagenous region and carboxyl peptide (10, 15, 16). By virtue of four internal 20–44-residue interruptions, the primary sequence of the unique type XIX collagenous region can be divided into five 70–224-residue subdomains; four include a few short interruptions, and the fifth is composed solely of Gly-X-Y triplets (1416) (illustrated in Fig. 12A). In contrast, only two or three collagenous subdomains are found in other members of the above mentioned subclass, except for type XVI, which is interspersed with a heterogeneous array of ~9–10 generally less well defined collagenous segments (24, 9, 10, 17).



View larger version (13K):
[in this window]
[in a new window]
 
FIG. 12.
Schematic diagram showing the shape of type XIX collagen, including comparison with the primary structure, localization of the kinks, and illustration of individual molecules. Part A, schematic diagram of the type XIX polypeptide chain, predicted from the amino acid sequence (1416), shows the collagenous subdomains (COL1–COL5) and noncollagenous (NC1–NC6) regions (numbered from carboxyl to amino according to the convention for this class of collagens; see Introduction). NC1 corresponds to the carboxyl peptide, and NC6 corresponds to the amino terminus. The numbers of amino acids in each segment are indicated in parentheses. Small interruptions (1–3 residues in COL5, COL4, and COL1 and 6 amino acids in COL3) are indicated as vertical black bars/lines. Each cysteine is designated by the letter C. Part B, Predicted size (nm) of the collagenous subdomains is based on the percentage of total length of the rodlike regions (220 nm = 240-nm molecular length –20-nm globular domain) from the number of amino acid residues shown in part A. Part C, schematic diagram of the position of kinks in type XIX collagen (Fig. 7) derived from analysis of electron microscope images (Fig. 6). The globular nodule is at the amino-terminal end and is followed by rodlike collagenous subdomains interrupted by noncollagenous segments, at which site kinks can occur. There are kinks at each of the long internal NC regions (P2, P4, P5, and P6); two additional kinks (P1 and P3) may correspond to two 3-amino acid interruptions. Cumulative distances in nm from the amino-terminal nodule to each of the kink regions are indicated. Part D, some possible conformations of type XIX collagen, from the diagram in part C and based on electron micrographs shown in Fig. 6. In some cases, the molecules are more extended, whereas in others there are sharp kinks imparting a zigzag shape.

 



View larger version (32K):
[in this window]
[in a new window]
 
FIG. 7.
Histogram showing the location of the sharp bends or kinks in the rod regions of type XIX collagen. Molecules were measured from the globular end, and the positions of the kinks are shown as peaks in the plot of the frequency of kinks versus the cumulative lengths. Molecules have up to six kinks, peaks P1–P6 in the histogram, but most molecules display fewer. The distance from the globular domain to each kink allows the identification of that kink with one of the histogram peaks. The numbers below P1–P6 represent the average distances in nm from the end of the molecule to each kink measured in the molecules displaying that kink(s).

 


View larger version (176K):
[in this window]
[in a new window]
 
FIG. 6.
Transmission electron micrographs of rotary-shadowed type XIX collagen molecules. This gallery of images illustrates the most commonly observed particles (a–l), which are long rodlike structures with a nodule at one end and several sharp bends or kinks. Some of the molecules are sharply kinked (a, d, f, j, and l) to such an extent that one portion of the rod folds back on the remainder of the molecule (g). Other molecules are kinked and more elongated (b, e, i, and k). Magnification bar, 50 nm.

 
Although knowledge of the type XIX chain spans a decade, there are few reports focused on the expression of this molecule, and its function remains obscure. In Western blots, polyclonal antibodies raised against amino and carboxyl noncollagenous terminal sequences, respectively, reacted with a 165-kDa collagenase-sensitive chain found in cultured RMS cell extracts (18). Light microscopy immunohistochemistry demonstrated that type XIX localized to endothelial, neuronal, mesenchymal, and most epithelial basement membrane zones (BMZ) in all human tissues tested: namely breast, colon, kidney, liver, placenta, prostate, skeletal muscle, skin, and spleen (18, 19). Curiously, separate data revealed another aspect of type XIX expression, a correlation with skeletal myogenesis. Type XIX RNA and protein were dramatically up-regulated in RMS cells cultured in growth factor-depleted serum (20); this induction was restricted to a small subpopulation of cells that also expressed structural proteins characteristic of skeletal muscle differentiation. In a subsequent report, it was shown that during mouse embryonic development, spatial and temporal expression of type XIX RNA was essentially coincident with the myf-5 transcription factor (21). Most recently, type XIX null mice with a perinatal lethal phenotype were used to establish that this collagen is required for complete esophageal muscle transdifferentiation.2

To begin direct exploration of this vital protein at the ultrastructural level, we have purified the native tissue form of type XIX and characterized the molecule by electron microscopy and biochemical analysis. Type XIX collagen in human umbilical cord is extremely scarce (i.e. ~106% of dry weight, which is several orders of magnitude less than any other collagen so far isolated). Electron microscope images revealed a sharply kinked and highly polymorphic collagenous region and the existence of higher order complexes. The involved amino-terminal domain is responsible for intermolecular disulfide linkages and contains a proven heparin-binding site.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Type XIX Polyclonal and Monoclonal Antibodies—The type XIX polyclonal antibody recognizing the last 14 residues of the carboxyl terminus (COOH-Ab) has been described previously (18). The antiserum was purified using Affi-Gel 10 resin (Bio-Rad), to which the peptide antigen was covalently bound. It was eluted in 1 M glycine, pH 2.7, and neutralized. The monoclonal antibody recognizing the amino-terminal domain of type XIX (NH2-Ab) was prepared by conventional methods (Genetics Core Facility, University of Pennsylvania) (22). The antigen was a 67-residue recombinant protein used to generate polyclonal antibodies (18). The type XIX COOH-Ab used for purification of type XIX protein was eluted from Affi-Gel 10 in 0.1 M citric acid, pH 2.7, and neutralized with 1 M HEPES, pH 9 (Sigma). Peak fractions (1–1.2 mg) were dialyzed against 0.1 M HEPES, pH 7.0, concentrated to 1.5 ml (Centricon-30; Millipore Corp., Bedford, MA), and bound to 1 ml of Affi-Gel 10. Western blotting showed that almost all of the antibody bound to the resin.

Purification of Type XIX Collagen—Human umbilical cords were obtained from the Hospital of the University of Pennsylvania. About 400 cord specimens totaling ~8 kg and weighing 3.5–56 g each were collected for this project. Cords were frozen temporarily at –20 °C and transferred to –80 °C. For large scale preparations, 10–15 specimens (~250 g, wet weight) were pooled and processed as described below; for rotary shadowing, two preparations were combined before the antibody affinity column. Processed tissue, protein samples, and buffers were maintained in an ice slurry when possible or else kept at 4 °C. Tissue was thawed on ice, washed several times in buffer (50 mM Tris-HCl, 4.5 M NaCl, 20 mM EDTA, pH 7.5, 10 mM N-ethylmaleimide, and 0.5 mM phenylmethylsulfonyl fluoride), cut into 0.5-cm pieces, and added to extraction buffer (10:1 (v/w) 50 mM Tris-HCl, 1.0 M NaCl, 10 mM EDTA, pH 7.5) with protease inhibitors (10 mM N-ethylmaleimide, 0.5 mM phenylmethylsulfonyl fluoride, 5 µg/ml leupeptin, 1 µg/ml aprotinin, all obtained from Sigma). The tissue was homogenized at speed 5 (speed 10 = 27,000 rpm) for 8 x 1 min (Polytron; Brinkman Instruments, Westbury, NY). The tissue suspension was stirred slowly for 21–24 h and centrifuged at 32,000 x g for 30 min. Supernatant proteins were precipitated overnight with the addition of ammonium sulfate to 40% saturation, centrifuged as above, resuspended in 200 ml of extraction buffer containing 0.1% Triton X-100, stirred overnight, and dialyzed for 4 h against 2 liters of buffer containing 25 mM Tris-HCl, 0.4 M NaCl, 2.0 mM EDTA, pH 7.4, 0.1% Triton X-100, and the inhibitors listed above. The sample was then dialyzed against the same buffer except with a lower pH (7.2) and NaCl (0.1 M) concentration. The mixture was clarified at 20,000 x g for 15 min, and the supernatant was incubated in a batch procedure with 40 ml of SP Sepharose Fast Flow resin (Amersham Biosciences) pre-equilibrated in the final dialysis buffer containing 0.1 M NaCl. The protein solution and resin were incubated on a rocker overnight and centrifuged at 480 x g for 5 min, and the resin was washed/eluted stepwise at 30-min intervals using 3 x 140 ml of the binding buffer and 4 x 80, 4 x 40, and 2 x 40 ml of the same buffer containing 0.3, 0.6, and 1.0 M NaCl, respectively. Type XIX collagen in the first two portions of the 0.6 M NaCl eluate was concentrated (~16–20-fold) (Ultracell Amicon YM 30 Ultrafiltration Discs; Millipore Corp.) and then brought to a final concentration of 0.4 M NaCl. The BCA reagent (Pierce) was used for protein assays.

The type XIX pool was mixed with Affi-Gel 10 resin (4:1, v/v) to which the purified COOH-Ab was bound. The resin was pre-equilibrated in 0.4 M NaCl buffer containing 25 mM Tris-HCl, 2.0 mM EDTA, pH 7.2, 10 mM N-ethylmaleimide, 0.5 mM phenylmethylsulfonyl fluoride, 1 µg/ml leupeptin, 1 µg/ml aprotinin (or 1 µg/ml pepstatin A), and 0.1% Triton X-100. The sample was incubated with the resin on a rocker platform for 8–16 h. The column was washed with 4 x 3mlof0.4 M NaCl binding buffer, and type XIX collagen was eluted stepwise in 0.8–1-ml fractions of 1.0 M glycine, pH 2.7, immediately neutralized with 1 M Tris base. Fractions were collected by gravity in polypropylene tubes precoated with Triton X-100 (0.1%). Before elution, Triton X-100 and EDTA, pH 7.2, were added to each tube in order to adjust the final concentration in each fraction to 0.1% and 2.0 mM, respectively. Protease inhibitors were added to each fraction immediately after collection. Fractions were aliquoted, frozen in dry ice, and stored at –80 °C, or the peak fraction was dialyzed against 0.1 M ammonium formate, pH 7.4, 1.0 mM EDTA, 0.1% Triton X-100, and protease inhibitors for 16 h for rotary shadowing. The microdialyzer (Spectrum, Gardena, CA) and membrane (molecular mass cut-off of 50 kDa) were pretreated with 0.1% Triton X-100.

Bacterial Collagenase Digestion—Collagenase digestion was carried out for 75 min at 37–38 °C in a 15-µl reaction containing 50 mM Tris-HCl, pH 7.2, 10 mM calcium acetate, and 2–5 units of bacterial collagenase form III (Advance Biofactures, Lynbrook, NY). Control samples (undigested) were incubated in the same buffer without collagenase.

Gel Electrophoresis and Western Blot Analysis—Samples were boiled for 2 min in 60 mM Tris-HCl, pH 6.8, 4% SDS, 10% glycerol, 50 mM EDTA, 0.025% bromphenol blue, 200 mM DTT and electrophoresed in 6, 7, 10, or 12% polyacrylamide-SDS gels. Proteins were transferred to Immobilon-P membranes (Millipore) (18, 23). Membranes were incubated for 90 min with the primary antibody (0.1–1 µg/ml of the COOH-Ab or a 1:100–200 dilution of serum-free medium from the clone producing the monoclonal NH2-Ab), washed, and incubated with secondary antibodies (anti-rabbit IgG, peroxidase-linked F(ab')2 fragment from donkey or anti-mouse IgG, peroxidase-linked whole antibody from sheep). Membranes were developed using ECL reagents (Amersham Biosciences).

Silver Staining—Type XIX protein was stained using the SilverXpress silver staining kit from Invitrogen (Carlsbad, CA) following the company's procedure for "samples reduced with DTT" with the following modifications. Samples were brought to a final concentration of 20 mM DTT, boiled for 2 min, and cooled to room temperature. Iodoacetamide was added to 0.1 M, and samples were incubated at 37 °C for 10 min before being applied to the gel. In addition, during the gel staining process, the second sensitizing step was increased from 30 to 60 min.

Immunohistochemistry—Human umbilical cord was obtained from Robert Wood Johnson University Hospital, snap-frozen in OCT compound in methylbutane at liquid nitrogen temperature, and sliced into 4-µm sections. The immunoperoxidase staining procedure has been detailed earlier (18, 19). Sections were incubated with the type XIX COOH-Ab (18) or a type IV collagen polyclonal antibody (DAKOpatts, Carpentaria, CA). Swine anti-rabbit secondary antibody and peroxidase-conjugated streptavidin were also obtained from DAKOpatts.

Heparin-Sepharose Chromatography—An aliquot (220 µg) of the SP Sepharose pool was diluted to 0.2 M NaCl and digested to completion with 100 units of bacterial collagenase for 3 h at 37 °C in 0.5 ml. EDTA was added to a final concentration of 20 mM, and the sample was diluted to 1 ml and applied to a 1-ml heparin-Sepharose HiTrap column (Amersham Biosciences) in a Tris-HCl, pH 7.4, buffer containing 0.1 M NaCl, 10 mM EDTA, and protease inhibitors. The column was washed with 7 ml each of 0.1 and 0.3 M NaCl buffers. The bound material was eluted in 1 M NaCl buffer in 0.3-ml fractions.

Rotary Shadowing Electron Microscopy—Type XIX collagen was visualized by electron microscopy of rotary-shadowed samples prepared by modifications of published methods (2426). Type XIX, eluted from the antibody affinity column, was dialyzed in ammonium formate as stated above, and autoclaved glycerol (99.5+% spectrophotometric grade; Aldrich) was added to give a final concentration of 50%. The sample was sprayed onto 0.5-cm2 pieces of freshly cleaved mica using an EFFA spray mount device (E. F. Fullam Inc., Latham, NY). The sheets of mica were then placed in a Denton DV-502 vacuum evaporator (Denton Vacuum, Cherry Hill, NJ) and pumped until the vacuum was about 3–4 x 107 torr. Tungsten was evaporated at an angle of about 4–7° while the stage containing the mica was rotating, and carbon was evaporated on top of the tungsten as a support layer. The replicas were floated off the mica onto a water surface and picked up onto 400-mesh copper grids and examined with a Philips EM 400T transmission electron microscope (Philips, Hillsboro, OR) at 80 kV. Many grids were examined, and micrographs were taken from a variety of areas at a magnification of generally x 60,000. In an alternative method (the Nagaswami technique) modified from previous reports (27), about 10 µl of the sample was applied to a piece of Parafilm on ice. A 0.5-cm2 piece of freshly cleaved mica was placed on the top of the droplet and allowed to remain on the ice for about 2 h. The mica was removed from the Parafilm, and the buffer described above (50% glycerol in ammonium formate buffer) was placed onto the mica. The excess solution was removed by blotting, and the mica was allowed to remain in the cold room overnight. The next day, rotary shadowing was carried out as described above.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Identification of Type XIX Collagen in Human Umbilical Cord Tissue by Western Blotting—Purification of the in vivo form of type XIX collagen depended upon two immediate factors. One was the ability to detect the protein with characterized antibodies raised against the terminal noncollagenous domains (18) (see "Materials and Methods"), and the second was finding a tissue source that could be obtained in sufficient amounts to isolate what was expected to be an extremely scarce protein. This limited human tissue to placenta and umbilical cord, whereas a number of bovine tissues were potentially available if the human antibodies cross-reacted. Immunoblots of crude extract prepared from human placenta and umbilical cord were negative for type XIX, so conventional procedures were employed to enrich the preparation for matrix proteins (28). Soluble material obtained from a 5 M NaCl precipitate following homogenization and 1 M NaCl extraction showed a convincing type XIX signal in human umbilical cord extract (Fig. 1, lanes 2 and 5). Both the type XIX NH2-Ab and COOH-Ab identified the expected 165-kDa collagenous protein (observed in Western blots of RMS cell extracts) (18, 20). No type XIX collagen was found using similarly treated human placenta or bovine cord samples (Fig. 1, lanes 1 and 4 and lanes 3 and 6, respectively). The former was consistent with the weak placenta immunostaining reported earlier (18), and the latter suggested that neither human antibody recognized bovine XIX.



View larger version (40K):
[in this window]
[in a new window]
 
FIG. 1.
Identification of type XIX collagen in human umbilical cord by Western blotting. Total protein was extracted from homogenized human placenta (lanes 1 and 4), and human and bovine umbilical cord (lanes 2 and 5, 3 and 6, respectively) in a neutral pH, 1 M NaCl buffer, precipitated using 5 M NaCl, and resuspended in extraction buffer. Sixty micrograms per lane were electrophoresed in a 6% polyacrylamide-SDS gel, subjected to Western blot, and reacted with the type XIX NH2-Ab (lanes 1–3) or COOH-Ab (lanes 4–6) as indicated. The 165-kDa type XIX band was not seen when the sample was incubated with bacterial collagenase prior to electrophoresis (data not shown).

 

Immunohistochemical Staining of Type XIX in Umbilical Cord—To corroborate the Western blotting result and to identify what structures type XIX was associated with in cord tissue, immunohistochemical analysis was conducted. The umbilical cord is covered by a simple amniotic epithelium and contains one vein and two arteries surrounded by a mucous connective tissue matrix, Wharton's jelly (2931). Type XIX was present in epithelial, smooth muscle, and endothelial BMZs (Fig. 2). The amniotic epithelial BMZ (upper left panel) and the BMZ surrounding the muscle cells of the vessels (upper right panel) were strongly reactive with the type XIX COOH-Ab. Within Wharton's jelly (upper left panel), type XIX staining showed a diffuse localization throughout the outer region, whereas in the portion of the cord adjacent to the large vessels, it appeared more condensed (data not shown). The BM/BMZ localization of type IV collagen (Fig. 2, lower panels) was comparable with type XIX, and in Wharton's jelly, the type IV staining was more uniform throughout the matrix (lower left panel).



View larger version (128K):
[in this window]
[in a new window]
 
FIG. 2.
Immunohistochemical localization of types XIX and IV collagen in human umbilical cord. The amniotic epithelial layer (e) BMZ (arrows) and Wharton's jelly (*) stain positive for types XIX (upper left) and IV collagen (lower left). Original magnification was x82. Type XIX (upper right) and type IV (lower right) are also present in the BMZ of the endothelium (arrowhead) and smooth muscle cells (curved arrows) of the vein as shown here and the two arteries (data not shown). l, vascular lumen. Original magnification was x41 for the type XIX illustration and x82 for type IV.

 

Purification of Type XIX Collagen by Neutral Salt Extraction and by Ion Exchange and Antibody Affinity Chromatography—A number of different sized umbilical cord pieces (usually 10–15) were pooled for each of the type XIX preparations; the maximum amount of tissue processed at one time was 250 g. Almost all of the type XIX collagen was extracted from homogenized tissue in a 1 M NaCl buffer, and subsequent concentration and fractionation using 40% saturated ammonium sulfate resulted in an excellent recovery (see "Materials and Methods"; data not shown). Following precipitation, the pellet was resuspended, dialyzed, and applied to an ion exchange resin. The choice was dictated by the 8.6 pI of the protein, and as predicted, type XIX exhibited a high affinity for the cation exchange resin, SP Sepharose (see "Materials and Methods"; data not shown). The protein was bound in a batch procedure at 0.1 M NaCl, completely retained after a 0.3 M NaCl wash, and eluted using 0.6 M NaCl, where >95% of the type XIX was recovered in the first two buffer applications. The ionic strength of the 0.6 M pools 1 and 2 corresponded to 0.44 and 0.55 M NaCl, respectively, reflecting mixture with the wash buffer. Western blotting of a final 1.0 M NaCl treatment of the resin was negative for type XIX.

In a silver-stained gel of the SP Sepharose 0.6 M NaCl pool, a probable type XIX band appeared as a very minor species in a heterogeneous array of various sized proteins (data not shown). This result verified the scarcity of type XIX and the absolute requirement for a specific mode of purification only afforded by an antibody affinity column. The SP Sepharose eluate was concentrated, diluted to 0.4 M NaCl, and mixed overnight with the type XIX COOH-Ab covalently bound to a gel matrix. The column elution profile was evaluated by Western blotting using both the NH2- and COOH-Abs (Fig. 3, A and B). A minimal amount of type XIX was found in the flow-through and wash (Fig. 3, lanes 2, 3, 9, and 10); type XIX eluted sharply in fraction 2, where the pH 2.7 glycine displaced the pH 7.2 equilibration and wash buffer (Fig. 3, lanes 5 and 12).



View larger version (25K):
[in this window]
[in a new window]
 
FIG. 3.
Complete purification of type XIX collagen using a COOH-Ab affinity column. Pools 1 and 2 from the SP Sepharose eluate (see "Materials and Methods") were concentrated, diluted to 0.4 M NaCl, and incubated with Affi-Gel resin to which the type XIX COOH-Ab was covalently bound. The aliquots used in lanes 1 and 2/lanes 8 and 9 and lanes 37/lanes 1014 were 0.2 and 0.4%, respectively, of the total volume. After Western blotting, the filters were incubated with the type XIX NH2-Ab (A) and the COOH-Ab (B). The 165-kDa band is the intact type XIX chain, and the 120- and 140-kDa bands appear to be cleavage fragments identified by the NH2-Ab and COOH-Ab, respectively. Lanes 7 and 14 show an aliquot of column fraction 2 incubated with bacterial collagenase before gel electrophoresis.

 

Different type XIX cleavage fragments were detected, depending upon the antibody used. Noticeable throughout the procedure, but somewhat increased in the purified fraction, was a ~120-kDa minor fragment identified by the NH2-Ab (Fig. 3A, lanes 1 and 5). A much more pronounced cleavage product was evident using the COOH-Ab; about one-third to one-half (depending upon the preparation) of type XIX was present in the form of a 140-kDa band that was seen before the column elution as a comparatively minor fraction (Fig. 3B, lanes 8 and 12). Despite the immediate addition of a variety of freshly prepared protease inhibitors to the fractions, the 140-kDa species (later visualized by electron microscopy) remained a significant portion of the type XIX recovered.

The yield and purity of type XIX was also determined by silver staining (Fig. 4). The 165-kDa intact chain and the 140-kDa degradation fragment were clearly seen; the 120-kDa fragment was faintly evident (Fig. 4, lane 1). All bands were digested with bacterial collagenase (Fig. 4, lane 2) and their identity and relative proportions verified by Western blotting of aliquots electrophoresed on parallel lanes (data not shown). The total amount of type XIX at this final step, too low for conventional protein assays to be employed, was estimated by comparing the intensity of the bands to a range of known amounts of type I collagen electrophoresed on adjacent lanes (data not shown). The results showed that ~1.5 µg of type XIX protein was purified from 230 to 250 g of umbilical cord tissue, translating to a representation of 6 x 106%. A flow diagram of the procedure, together with absolute and relative amounts of protein recovered at each step, is shown in Fig. 5.



View larger version (16K):
[in this window]
[in a new window]
 
FIG. 4.
Silver-stained gel of purified type XIX collagen. About 40 ng of purified type XIX collagen was electrophoresed under reducing conditions on a 7% SDS-polyacrylamide gel after incubation in the absence (–) (lane 1) or presence (+) of bacterial collagenase (lane 2). The gel was silver-stained as described under "Materials and Methods." In lane 1, the 165-kDa intact type XIX chain is seen along with the dominant 140-kDa cleavage fragment and the barely visible 120-kDa fragment. The identity of each band was corroborated by Western blotting (data not shown but comparable with the fraction 2 profile in Fig. 3). The bands seen in lane 2 (arrowheads) are the collagenase enzyme.

 


View larger version (26K):
[in this window]
[in a new window]
 
FIG. 5.
Schematic diagram of the type XIX collagen purification. Details of the purification are provided under "Materials and Methods." The values shown are averaged from five preparations with little variation. At each step following the 1 M NaCl extraction, >90% of the starting material was accounted for (e.g. SP Sepharose flow-through of 1255 mg, 0.3 M NaCl pool of 92 mg, and 0.6 M NaCl pool of 11 mg = 1358 mg, which is 93% of the 1460-mg column load). The percentage recovery at each step was calculated using the original dry weight value of umbilical cord tissue. Boxes outlined with thick lines show the fraction in which type XIX collagen was recovered. The yield of purified type XIX, ~6 x 106%, was estimated by comparing the intensity of type XIX samples (20–50-ng total for all three bands) with a range of known amounts of type I collagen electrophoresed on the same gel and silver-stained. The minimum amount of type XIX required for the standard protein assay, at least 5 µg, was prohibitive to sacrifice for this purpose.

 

The Unique Shape of Type XIX Collagen as Visualized by Electron Microscopy—The purified native type XIX collagen was examined by transmission electron microscopy following rotary shadowing with tungsten in a vacuum evaporator. Eight independent experiments were carried out using type XIX collagen alone and/or type XIX incubated with the COOH- or NH2-Ab. Visualization of the grids containing type XIX alone revealed that most of the individual particles were long, rodlike structures with multiple kinks or bends and a small nodule at one end (Fig. 6), indicating that this is the shape of the type XIX molecule. The dimensions of the structures observed were determined. The mean diameter of the globular region was 19.7 ± 2.6 nm (n = 40). The mean length of the rods could not be established directly because of the many different combinations and angles of the kinks. Instead, individual segments were measured, and a histogram was constructed to show the average positions of the kinks relative to the end of the molecule as defined by the globular region (Fig. 7). Six peaks (P1–P6) representing the sites of the major kinks were identified; they were located at 52 (P1), 70 (P2), 85 (P3), 135 (P4), 170 (P5), and 215 (P6) nm. Whereas these distances are the averages of all molecules containing each of these kinks, it should be noted that not all molecules contain all of the kinks (Fig. 6). Some peaks are broad, suggesting that there may be variability in the location of the kinks. Such differences can be accounted for if portions of some molecules were not lying flat on the surface when they were sprayed. In this case, the images observed would be projections of the individual rod segments with correspondingly shorter lengths, depending upon how steeply they were angled. Such behavior would be expected for rigid collagen rods. Some of the variation could also be explained because the bend could occur at different sites in the four large noncollagenous (NC) segments (20–44 residues) as well as within the nine smaller interruptions (1–6 residues) that occur in four of the five collagenous subdomains (a schematic diagram of the chain is shown in Fig. 12A). The mean total length of the whole molecule was estimated at 240 ± 23 nm.

Other structures commonly seen in the micrographs were long, thin, kinked rods without any globular domains at the end and globular nodules alone (data not shown). Many of the nodules were identical in size and shape to those at one end of the most commonly observed structures shown in Fig. 6. Other particles had the appearance of two or more nodules associating with each other. The rods were identical to the rod portion of the structures that also contained a nodule at one end (Fig. 6). It was apparent that the separated nodules and rods are, as described above in the purification process (Figs. 3 and 4), cleavage products of the larger, intact structures.

Polyclonal and monoclonal antibodies to the type XIX carboxyl- and amino-terminal ends, respectively, were used to identify those portions of the structures (Fig. 8). Rotary-shadowed IgG antibodies appear by electron microscopy to be three-lobed structures in which the relationship among the lobes is highly variable because of their flexibility (32). Many different views of various antibody conformations are visible. After incubation of the antibodies with type XIX collagen, the complexes were rotary-shadowed and studied by electron microscopy. The type XIX polyclonal COOH-Ab bound to the end of the collagen opposite from the nodule, verifying the location of the short carboxyl-terminal peptide (Fig. 8A). In contrast, images of type XIX collagen incubated with the monoclonal NH2-Ab show that this IgG molecule bound to the nodule itself, corroborating that this is the amino-terminal noncollagenous domain (Fig. 8B).



View larger version (152K):
[in this window]
[in a new window]
 
FIG. 8.
Electron micrographs of rotary-shadowed type XIX collagen complexed with antibodies to the carboxyl- and amino-terminal domains. Purified type XIX was incubated for 60–75 min at room temperature with a 1:1 or 1:2 ratio of collagen to antibody. A, the COOH-Ab binds to the rod at the end opposite to the small nodule. In some cases, the three lobes of the IgG are visible (arrowheads). B, the NH2-Ab (arrowheads) binds to the globular region, identifying it as the amino-terminal end. Magnification bar, 50 nm.

 

Identification of Type XIX Amino-terminal Linked Complexes—In the electron micrographs of all preparations of type XIX, there were many aggregates of the collagen molecules. These almost invariably interacted with each other via their globular amino-terminal ends (Fig. 9). In most cases, the number of molecules in each aggregate could be extrapolated from the number of rodlike tails extending away from the core containing the interacting nodules. All molecules, both those interacting with each other and the individual ones, were counted in many micrographs, yielding an estimate of the proportion of multimers. Total percentages for each size oligomer (n = 300) were as follows: monomer, 43.7%; dimer, 25.9%; trimer, 8.9%; tetramer, 7.4%; pentamer, 7.4%; hexamer or larger, 6.7%. In some instances, these structures were too intricate to accurately assess the number of constituent molecules. Also seen in the micrographs were examples of a higher level of type XIX organization; a classic representative is shown in Fig. 9 (large panel). These featured clusters of the aggregates described above and comprised a great many individual type XIX molecules.



View larger version (235K):
[in this window]
[in a new window]
 
FIG. 9.
Electron microscope images of rotary shadowed aggregates of type XIX molecules. The five small panels show the interaction of 2–6 or more collagen molecules via their globular domains, so that the tails extend radially from the heads. More than half of the molecules were present in such aggregates. As seen in Fig. 6, the tails often contain multiple kinks, hindering a precise count of the number of molecules. The large image illustrates a higher order structure that appears to consist of smaller individual aggregates joined at the amino termini and is not just a larger version of one aggregate. None of the fields included an abundance of collagen molecules; therefore, the structures seen here are not the result of random juxtaposition on the surface and thus may well represent in vivo forms. Magnification bar, 50 nm.

 

To further ascertain the nature of the amino-terminal interactions, Western blotting of purified type XIX was conducted under different conditions using the NH2-Ab as probe (Fig. 10). As reported earlier for type XIX synthesized by RMS cells (18), in the absence of reducing agent, all of the intact type XIX molecules were found in the stacking gel or at the top of the separating gel (Fig. 10, lane 1). No individual 165-kDa chains or lower molecular mass species were detected, showing that the bands revealed in lanes 2 and 3 were a function of the treatment indicated. Type XIX, digested with collagenase and electrophoresed under nonreducing conditions, appeared mainly in the form of several bands ranging in size from ~110 to >=250 kDa (Fig. 10, lane 2). A band of ~60 kDa was also seen. In the presence of DTT (Fig. 10, lane 3), the amino fragment migrated as a 34-kDa band (previously shown for collagenase-treated, RMS type XIX) (18). (The minor band of 29 kDa is due to a secondary cleavage site for collagenase.) The 110-kDa band (3 x 34 kDa) would represent the cleaved amino terminus of a monomer (linked by interchain bonds), and the higher molecular weight bands correspond to this domain in the oligomers. The intensity of the larger fragments will be underrepresented compared with smaller ones due to the decrease in transfer efficiency. Consistent with the electron microscopy images, these results independently show that the type XIX molecules associate via their amino-terminal domains and furthermore reveal that this complex occurs by formation of intermolecular disulfide cross-links.



View larger version (20K):
[in this window]
[in a new window]
 
FIG. 10.
Biochemical characterization of the type XIX amino-terminal domain. Aliquots of purified type XIX collagen were digested with bacterial collagenase (+), electrophoresed on a 10% SDS-polyacrylamide gel in the absence (– in lane 2) or presence (+ in lane 3) of 200 mM DTT, subjected to Western blot, and reacted with the type XIX NH2-Ab. All of the bands seen in lanes 2 and 3 appear only after collagenase digestion and reduction as illustrated in lane 1, where undigested, unreduced type XIX is found solely in the stacking gel and at the top of the separating gel. In the unreduced, collagenase-treated sample (lane 2), the ~110-kDa band (arrowhead) most likely originates from a single type XIX molecule linked by interchain disulfide bonds. The higher molecular weight bands (brace), more accurately sized on a 6% gel (not shown), range from ~160 to >=210 kDa. These would correspond to the type XIX aggregates shown in Fig. 9, reflecting the existence of intermolecular cystine linkages. The 60-kDa band may represent a degradation product. Note that the intensity of the bands is inversely proportional to their size because of the decrease in transfer of high molecular weight proteins, especially on a 10% gel. In the reduced sample (lane 3), the type XIX amino-terminal domain migrates primarily at 34 kDa (arrow). Other data (not shown) have revealed the existence of secondary collagenase cleavage sites that give rise to 29- and 60-kDa bands.

 

The Type XIX Amino Terminus Contains a Heparin-binding Site—The type XIX amino terminus has been characterized as a Tsp-N module (10, 33, 34), and specific functions of thrombospondin-1 (TSP-1) have been mapped to this domain (reviewed in Refs. 35 and 36). Alignment of the modules in type XIX and TSP-1 revealed about 15% absolute identity as dispersed single residues or doublets (data not shown). The most conspicuous homology was the TSP-1 motif (RXXKKXR) (37) embedded in a longer basic residue sequence (RXRRXXKKXR) in type XIX (16). The KKXR peptide is a known TSP-1 heparin-binding site (38).

To ascertain whether this site in type XIX is functional, the SP Sepharose peak was digested with collagenase and applied to a heparin-Sepharose column. Western blotting demonstrated that all of the type XIX amino-terminal fragment bound to the column in 0.1 M NaCl, was retained after a 0.3 M NaCl wash, and eluted sharply in a 1 M NaCl buffer (Fig. 11). Prior chromatography showed that the fragment gradient-eluted at 0.70–0.75 M NaCl.



View larger version (40K):
[in this window]
[in a new window]
 
FIG. 11.
The type XIX amino-terminal domain contains a heparin-binding site. Samples as described below were electrophoresed in a 12% polyacrylamide-SDS gel, subjected to Western blot, and probed with the type XIX NH2-Ab. An aliquot of the collagenase-digested SP Sepharose peak was loaded on a heparin Sepharose column in 0.1 M NaCl (lane 1); no signal was found in the flow-through or the 0.3 M NaCl wash (lanes 2 and 3, respectively). The 34-kDa fragment (arrow) was eluted in 0.3-ml fractions in a 1 M NaCl buffer. (Prior chromatography showed that the fragment gradient-eluted at 0.70–0.75 M NaCl.) An aliquot of fractions 10–14 is shown in lanes 4–8. The 29-kDa fragment originates from a secondary collagenase cleavage site.

 


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
We have performed the first direct biochemical and structural characterization of type XIX collagen. Prior to this report, all information has been deduced from the DNA sequence and immunoblots of type XIX found in RMS cell extracts. The identity of type XIX purified from human tissue was conclusively established using antibodies raised against the carboxyl-terminal peptide and the middle of the amino-terminal noncollagenous domain.

Type XIX Is a Rare Protein in Human Tissue—Type XIX is by far the least abundant collagen so far purified, with a representation of ~106% of the dry weight of umbilical cord (even less than type VII collagen, which is ~0.001% of pepsin-digested skin tissue) (39). This value should be reasonably accurate, since the relative amount of type XIX at each stage was monitored to assess the recovery. Once optimized, the isolation procedure was straightforward and designed to minimize loss by capitalizing on favorable type XIX properties. Type XIX was readily extracted from tissue using mild conditions, showing that it is not incorporated into an insoluble matrix complex. At the next stage, an inefficient 5 M NaCl precipitation was effectively replaced by use of 40% saturated ammonium sulfate, and type XIX in the pelleted material was completely soluble in neutral salt buffer. Strong affinity for a cation exchanger allowed for a stringent wash and complete disassociation from the resin using a high salt buffer. The rapid batch procedure was not replaced by gradient column elution, since it was clear that ion exchange chromatography just served as a prerequisite for specific capture by a type XIX antibody (Fig. 3). The former step afforded an ~2000-fold enrichment and the latter an additional ~7000-fold (totaling ~1.4 x 107). The strategy exemplified here (Fig. 5) may provide a blueprint for purification of other extremely rare collagens. Only the COOH-Ab bound to native type XIX, consistent with its ability to also recognize the protein by immunohistochemistry (18, 19). The NH2-Ab was ineffective in both respects, probably due to inaccessibility of the epitope within the clusters visualized by rotary shadowing.

Proteolysis Results in Discrete Type XIX Cleavage Fragments—Two particularly labile sites resulted in distinct cleavage products that were detected in Western blots and silver-stained gels (Figs. 3 and 4). The type XIX NH2-Ab reacted with a minor 120-kDa form that is probably generated from cleavage in NC3, the 23-amino acid interruption (identified as flexible site P5 in Fig. 12C) separating COL3 from the uninterrupted COL2 subdomain. Although NC3 is 301 residues from the carboxyl terminus, this length corresponds to ~45 kDa, considering that the 1119-residue type XIX chain migrates as 165-kDa by SDS-PAGE, 1.5 times the estimated size. (This retarded mobility is characteristic of collagen chains.)

The 140-kDa degradation product, identified only by the COOH-Ab, increased considerably after elution from the antibody column, where type XIX, at an ~2 µg/ml concentration, is sensitive to even a trace amount of protease. The cleavage is predicted to be near the junction of the 30-kDa amino terminus (not to be confused with the 34-kDa collagenase-generated fragment) and COL5 (see Fig. 12A). Accordingly, globular domains separated from the kinked rods were prominent in rotary-shadowed images, and their shape was the same as the corresponding regions in the intact molecule. Three lysines are located within the last 14 residues of the type XIX amino terminus (14); the middle one is a KD sequence found at the equivalent position in the TSP-1 Tsp-N module (37), where it is highly susceptible to trypsin cleavage (40). Identification of the type XIX site will require a more abundant source of protein to obtain the amount needed for sequencing. Characterization of these labile sites may prove important in studies of type XIX catabolism and matrix remodeling.

The Type XIX Molecule Can Assume Many Conformations— Electron microscopy established that individual type XIX molecules span 240 nm, terminate with a small nodule at the amino end, and contain rodlike collagenous domains interrupted by sharp bends. The 220-nm length, estimated for the sum total of the collagenous rods, agrees well with the established value of 0.286 nm/residue (41); 712 residues x 0.286 = 204 nm, which would be a minimum, since the residues in NC5-2 could not be measured.

A wide array of different type XIX images was observed (Fig. 6, a–l). The histogram (Fig. 7) indicated that there are up to six highly flexible regions. Some type XIX molecules display all six kinks, whereas others have fewer; not all hinge regions are always apparent. There are examples of extended molecules with one or two kinks; these contrast with others that are highly bent and assume a "zigzag" shape (Fig. 6, a, e, k, and l). In some cases, the angles are so pronounced that a part of the molecule folds back on itself (Fig. 6, b, d, and g–j). Another flexible site may flank the amino terminus, where cleavage of exposed residues could give rise to the 140-kDa fragment; however, this remains unresolved, since a rod emanating from the nodule radially or tangentially cannot be easily differentiated.

A high correlation exists between the positions of the six major kinks and the internal NC segments. The five predicted type XIX collagenous subdomains are composed of 144, 224, 108, 168, and 70 amino acids (Fig. 12A), which would represent 20, 31, 15, 23.5, and 10%, respectively, of 220 nm. The length of each of these rods would therefore be 44, 68, 33, 52, and 23 nm, (discounting the NC5–2 segments), and the cumulative distance to the bends would be 64 (i.e. 44 + 20 nm), 132, 165, 217, and 240 nm (Fig. 12B). An illustration depicting the spatial relationship of the kinks (P1–P6 peaks in Fig. 7) to the type XIX domain structure reveals a remarkable coincidence of P2, P4, P5, and P6 with NC5, NC4, NC3, and NC2, respectively. The other two bends, P1 and P3, closely align with three-residue interruptions in COL5 and COL4. Extreme flexibility at such sites is not surprising, since in osteogenesis imperfecta even a single glycine substitution in type I collagen was shown to cause kinks (4244).

The nonfibrillar collagens contain various size interruptions in the collagenous region; electron microscopy has been carried out to visualize some of these molecules (see Ref. 10 and references therein and Refs. 4547). The kinks/bends that have been observed are often difficult to map to specific interruptions when the collagenous subdomains are not as defined as they are in type XIX and related family members (see Introduction). Alternatively, it is known that the presence of even large noncollagenous segments does not necessarily extrapolate into kinks as seen for the three-subdomain type IX collagenous region. Only one kink, equivalent to the 12–17-residue NC3 and the site of glycosaminoglycan chain attachment, is seen by electron microscopy despite the presence of a 30-residue NC2 segment (10, 48). In type XIX, manifestation of all of the large and at least several of the small interruptions into highly flexible sites results in the most polymorphic collagen so far characterized. The interruptions support numerous spatial configurations (illustrated in Fig. 12D) and, in this regard, can confer a high degree of adaptability to the microenvironment by differentially positioning the rigid collagenous subdomains. Moreover, the long, extensible NC segments may, in particular, represent binding sites whose availability can be modulated by the degree to which the residues are exposed to other matrix molecules. Taken together, the permutations in the type XIX structure are considerable, and even subtle differences may influence many biological processes.

The Supramolecular Assembly of Type XIX Is Dependent upon Amino-terminal Interactions—More than half the type XIX collagen molecules were present in oligomers interacting via their amino-terminal ends, suggesting that these complexes are physiologically significant. It is very unlikely that they could be attributed to a technical artifact, since the inherent low density of the type XIX molecules sprayed onto the surface never favored a crowded environment. There are many examples of self-assembly of biological systems, but structural proteins in particular are "built to assemble." In other words, the binding interactions that are required for organization of some biological structures (exemplified, in fact, by collagens) (8, 10) are often manifested in the purified protein(s), and therefore supramolecular aggregates observed by electron microscopy commonly reflect aspects of their in vivo assembly.

Nonfibrillar collagens, with most still to be characterized, are known to organize into diverse higher order structures (e.g. polygonal networks, hexagonal lattices, beaded filaments, antiparallel dimer filaments, and direct association with fibrillar collagens) (reviewed in Refs. 1, 2, 8, and 10). They occur through end-to-end and/or side-by-side interactions, and many, as shown here for type XIX, are stabilized by intermolecular disulfide cross-links. The type XIX arrangement represents a previously unknown structure. The only visual parallel is the type X collagen aggregates, which were found in cultured cells expressing the endogenous or recombinant protein (49, 50). The individual type X molecules radiate from a globular carboxyl-terminal (not amino-terminal) core, and these complexes appear to interconnect through antiparallel overlap of rodlike triple helices (8, 10, 49). As demonstrated in the type X studies (49, 50), immunoelectron microscopy and molecular aggregation using a recombinant form may prove useful to further elucidate the type XIX structure.

Potential Biological Significance of the Type XIX Amino Terminus—Knowledge of the Tsp-N domain in other systems may provide important clues about the role of the type XIX amino terminus. The Tsp-N module is found in about 100 proteins, particularly those multidomain adhesive proteins that act as molecular bridges between cells and matrix and participate in cell-cell communication (51). Tsp-N contains patterns of alternating hydrophobicity characteristic of anti-parallel {beta} strands, and the presence of the predicted sandwiches appears, at least in part, to dictate the conserved, known and predicted, structural homology (34). A high propensity for {beta} sheet formation is also found in the Tsp-N/amino terminus of type XIX (14). Functions ascribed to Tsp-N of TSP-1 include cell adhesion, spreading, and migration; binding to glycosaminoglycan chains; disruption of focal contacts; regulation of proliferation; endocytosis; and platelet aggregation (35). Statistical analysis corroborated by the crystal structure has also shown a similarity of Tsp-N to the laminin G module, which shares a number of the aforementioned activities in addition to signaling, assembly, and differentiation (51, 52). The Tsp-N module is found too in TSP-like NELL proteins that are involved in neurogenesis and the maintenance of neuronal plasticity (53).

The Tsp-N module is also present in collagens IX, XII, XIV, and XVI (10, 17, 33, 34), but the KKXR heparin-binding site in TSP-1 is only conserved in type XIX. It has been shown that TSP-1, mediated by the Tsp-N module, binds to cells and is internalized and degraded in a process that requires heparan sulfate proteoglycans (5456). One can speculate that the type XIX oligomers may function as a nidus to increase the local concentration of signaling/structural molecules by associating with multiple extracellular matrix heparan sulfate proteoglycans, and/or type XIX could serve as a cell-cell/cell-matrix adhesive protein by binding to transmembrane heparan sulfate proteoglycans, like the syndecans, as has been established for TSP-1 (35, 36). Taken together, the results shown here provide a solid foundation for approaching functional studies of type XIX in the basement membrane/zone and in myogenic processes.


    FOOTNOTES
 
* These studies were supported by National Institutes of Health Grants GM64777, AR20553, and HL30954. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

§ To whom correspondence should be addressed: University of Pennsylvania School of Medicine, Dept. of Biochemistry and Biophysics, 909 Stellar Chance, 422 Curie Blvd., Philadelphia, PA 19104-6059. Tel.: 215-898-0712; Fax: 215-573-2085; E-mail: myers{at}mail.med.upenn.edu.

1 The abbreviations used are: RMS, rhabdomyosarcoma; Tsp-N, thrombospondin-amino terminal domain; BMZ, basement membrane zone; COOH-Ab, type XIX antibody recognizing the noncollagenous carboxyl peptide; NH2-Ab, type XIX antibody recognizing the amino-terminal noncollagenous domain; TSP-1, thrombospondin-1; NC, noncollagenous; COL, collagenous subdomain; DTT, dithiothreitol. Back

2 F. Ramirez, personal communication. Back


    ACKNOWLEDGMENTS
 
We thank Dr. Francesco Ramirez for providing information prior to publication. We have had valuable assistance/advice in different aspects of this project from Donna Hardy (Bio-Rad) and Dr. Marcos Milla as well as from Fangping Zhou, Kelly Walton, and Nicole Scivoletti. We appreciate the kind gift of highly purified bacterial collagenase from Dr. Bo Yu (Advance Biofactures). We are especially indebted to the many people (residents, attending physicians, nurses, house staff) in the Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, for saving >400 cord specimens over a period of 2 years. The enthusiastic support of Dr. Matheu Beshara, who initiated the effort, and Dr. Jerome F. Strauss III, who first approved the arrangement, is very gratefully acknowledged.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Myllyharju, M., and Kivirikko, K. I. (2001) Ann. Med. 33, 7–21[Medline] [Order article via Infotrieve]
  2. Kielty, C. M., and Grant, M. E. (2002) in Connective Tissue and Its Heritable Disorders (Royce, P. M., and Steinman, B., eds) pp. 159–221, Wiley-Liss, Inc., New York
  3. Koch, M., Foley, J. E., Hahn, R., Zhou, P., Burgeson, R. E., Gerecke, D. R., and Gordon, M. K. (2001) J. Biol. Chem. 276, 23120–23126[Abstract/Free Full Text]
  4. Fitzgerald, J., and Bateman, J. F. (2001) FEBS Lett. 505, 275–280[CrossRef][Medline] [Order article via Infotrieve]
  5. Hashimoto, T., Wakabayashi, T., Watanabe, A., Kowa, H., Hosoda, R., Nakamura, A., Kanazawa, I., Arai, T., Takio, K., Mann, D. M. A., and Iwatsubo, T. (2002) EMBO J. 21, 1524–1534[CrossRef][Medline] [Order article via Infotrieve]
  6. Sato, K., Yomogida, K., Wada, T., Yorihuzi, T., Nishimune, Y., Hosokawa, N., and Nagata, K. (2002) J. Biol. Chem. 277, 37678–37684[Abstract/Free Full Text]
  7. Banyard, J., Bao, L., and Zetter, B. R. (2003) J. Biol. Chem. 278, 20989–20994[Abstract/Free Full Text]
  8. van der Rest, M., and Garrone, R. (1991) FASEB J. 5, 2814–2823[Abstract]
  9. Brown, J. C., and Timpl, R. (1995) Int. Arch. Allergy Immunol. 107, 484–490[Medline] [Order article via Infotrieve]
  10. Ricard-Blum, S., Dublet, B., and van der Rest, M. (2000) Unconventional Collagens: Types VI, VII, VIII, IX, X, XII, XIV, XVI, and XIX, 1st Ed., Oxford University Press, New York
  11. Prockop, D. J., and Kivirikko, K. I. (1995) Annu. Rev. Biochem. 64, 403–434[CrossRef][Medline] [Order article via Infotrieve]
  12. Bruckner-Tuderman, L., and Bruckner, P. (1998) J. Mol. Med. 76, 226–237[CrossRef][Medline] [Order article via Infotrieve]
  13. Yoshioka, H., Zhang, H., Ramirez, F., Mattei, M.-G., Moradi-Ameli, M., van der Rest, M., and Gordon, M. K. (1992) Genomics 13, 884–886[CrossRef][Medline] [Order article via Infotrieve]
  14. Myers, J. C., Sun, M. J., D'Ippolito, J. A., Jabs, E. W., Neilson, E. G., and Dion, A. S. (1993) Gene (Amst.) 123, 211–217[CrossRef][Medline] [Order article via Infotrieve]
  15. Myers, J. C., Yang, H., D'Ippolito, J. A., Presente, A., Miller, M. K., and Dion, A. S. (1994) J. Biol. Chem. 269, 18549–18557[Abstract/Free Full Text]
  16. Inoguchi, K., Yoshioka, H., Khaleduzzaman, M., and Ninomiya, Y. (1995) J. Biochem. (Tokyo) 117, 137–146[Abstract/Free Full Text]
  17. Pan, T.-C., Zhang, R.-Z., Mattei, M.-G., Timpl, R., and Chu, M.-L. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 6565–6569[Abstract/Free Full Text]
  18. Myers, J. C., Li, D., Bageris, A., Abraham, V., Dion, A. S., and Amenta, P. S. (1997) Am. J. Pathol. 151, 1729–1740[Abstract]
  19. Amenta, P. S., Hadad, S., Lee, M. T., Barnard, N., Li, D., and Myers, J. C. (2003) J. Pathol. 199, 298–308[CrossRef][Medline] [Order article via Infotrieve]
  20. Myers, J. C., Li, D., Rubinstein, N. A., and Clark, C. C. (1999) Exp. Cell Res. 253, 587–598[CrossRef][Medline] [Order article via Infotrieve]
  21. Sumiyoshi, H., Laub, F., Yoshioka, H., and Ramirez, F. (2001) Dev. Dyn. 220, 155–162